Bristol Myers Squibb · company speakers →
discussed BMS-986449, a small molecule that selectively degrades transcription factors Helios (IKZF2) and Eos (IKZF4) to reprogram immunosuppressive regulatory T cells and promote effector activity.
Is this you? Claim this profile →
No public contact links on file.
Sourcing speakers for your event?
Browse the speaker directory →